SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?


To: A.J. Mullen who wrote (1386)3/19/2000 12:25:00 AM
From: George Sepetjian  Read Replies (1) | Respond to of 3202
 
The Patent Count

Here are the numbers as provided in an Editorial from the latest Barrons.

By a count provided by Human Genome Sciences, Incyte holds 353 U.S. patents on human genetic structures, Human Genome Sciences has 114 patents, SmithKline Beecham has 60, the U.S. government itself has 49, the University of California has 46 and Massachusetts General Hospital in Boston has 45.